Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 39 Records) |
| Query Trace: Epilepsy and CYP2C19[original query] |
|---|
| Effects of polymorphisms in six candidate genes on phenytoin maintenance therapy in Han Chinese patients. Pharmacogenomics 2012 Sep 13 (12): 1339-49. Hung Chin-Chuan, Huang Hsiao-Ching, Gao Yun-Han, Chang Wei-Lun, Ho Jia-Ling, Chiou Mu-Han, Hsieh Yow-Wen, Liou Horng-Hu |
| Influence of CYP2C19 polymorphism and concomitant antiepileptic drugs on serum clobazam and N-desmethyl clobazam concentrations in patients with epilepsy. Therapeutic drug monitoring 2013 Jun 35 (3): 305-12. Yamamoto Yoshiaki, Takahashi Yukitoshi, Imai Katsumi, Miyakawa Kou, Nishimura Shigeko, Kasai Risa, Ikeda Hiroko, Takayama Rumiko, Mogami Yukiko, Yamaguchi Tokito, Terada Kiyohito, Matsuda Kazumi, Inoue Yushi, Kagawa Yoshiyu |
| The effect of genetic polymorphisms of cytochrome P450 CYP2C9, CYP2C19, and CYP2D6 on drug-resistant epilepsy in Turkish children. Molecular diagnosis & therapy 2014 Apr 18 (2): 229-36. Seven Mehmet, Batar Bahadir, Unal Selin, Yesil Gozde, Yuksel Adnan, Guven Mehm |
| Pharmacogenetic evaluation of ABCB1, Cyp2C9, Cyp2C19 and methylene tetrahydrofolate reductase polymorphisms in teratogenicity of anti-epileptic drugs in women with epilepsy. Annals of Indian Academy of Neurology 2014 Jul 17 (3): 259-66. Jose Manna, Banerjee Moinak, Mathew Anila, Bharadwaj Tashi, Vijayan Neetha, Thomas Sanjeev |
| Individualized phenytoin therapy for Japanese pediatric patients with epilepsy based on CYP2C9 and CYP2C19 genotypes. Therapeutic drug monitoring 2015 Apr 37 (2): 229-35. Yamamoto Yoshiaki, Takahashi Yukitoshi, Imai Katsumi, Miyakawa Kou, Ikeda Hiroko, Ueda Yuki, Yamaguchi Tokito, Nasu Hirosato, Ohtani Hideyuki, Shigematsu Hideo, Kagawa Yoshiyuki, Inoue Yus |
| Association of polymorphisms of CYP2C9, CYP2C19, and ABCB1, and activity of P-glycoprotein with response to anti-epileptic drugs. Journal of postgraduate medicine 0 60 (3): 265-9. Taur S R, Kulkarni N B, Gandhe P P, Thelma B K, Ravat S H, Gogtay N J, Thatte U |
| Brivaracetam single and multiple rising oral dose study in healthy Japanese participants: influence of CYP2C19 genotype. Drug metabolism and pharmacokinetics 2014 29 (5): 394-9. Stockis Armel, Watanabe Shikiko, Rouits Elisabeth, Matsuguma Kyoko, Irie Sh |
| Effect of CYP2C19 polymorphisms on the clinical outcome of low-dose clobazam therapy in Japanese patients with epilepsy. European journal of clinical pharmacology 2015 Jan 71 (1): 51-8. Hashi Sachiyo, Yano Ikuko, Shibata Mai, Masuda Satohiro, Kinoshita Masako, Matsumoto Riki, Ikeda Akio, Takahashi Ryosuke, Matsubara Kaz |
| The effect of polymorphic metabolism enzymes on serum phenytoin level. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2015 Mar 36 (3): 397-401. Ozkaynakci Aydan, Gulcebi Medine Idrizoglu, Ergeç Deniz, Ulucan Korkut, Uzan Mustafa, Ozkara Cigdem, Guney Ilter, Onat Filiz Yilm |
| Cytochrome P450 2C19 polymorphisms and valproic acid-induced weight gain. Acta neurologica Scandinavica 2015 Jul . Noai M, Soraoka H, Kajiwara A, Tanamachi Y, Oniki K, Nakagawa K, Ishitsu T, Saruwatari |
| CYP2C9, CYP2C19, ABCB1 genetic polymorphisms and phenytoin plasma concentrations in Mexican-Mestizo patients with epilepsy. The pharmacogenomics journal 2015 Jun . Ortega-Vázquez A, Dorado P, Fricke-Galindo I, Jung-Cook H, Monroy-Jaramillo N, Martínez-Juárez I E, Familiar-López I, Peñas-Lledó E, LLerena A, López-López |
| Impact of Genetic Polymorphisms on Phenytoin Pharmacokinetics and Clinical Outcomes in the Middle East and North Africa Region. Drugs in R&D 2017 Jul . Dagenais Renée, Wilby Kyle John, Elewa Hazem, Ensom Mary H |
| Influence of genetic variants of CYP2D6, CYP2C9, CYP2C19 and CYP3A4 on antiepileptic drug metabolism in pediatric patients with refractory epilepsy. Pharmacological reports : PR 2017 Jan 69 (3): 504-511. López-García Miguel A, Feria-Romero Iris A, Serrano Héctor, Rayo-Mares Darío, Fagiolino Pietro, Vázquez Marta, Escamilla-Núñez Consuelo, Grijalva Israel, Escalante-Santiago David, Orozco-Suarez Sand |
| A prospective study to assess the association between genotype, phenotype and Prakriti in individuals on phenytoin monotherapy. Journal of Ayurveda and integrative medicine 2017 Mar . Thaker Saket J, Gandhe Prajakta P, Godbole Charuta J, Bendkhale Shital R, Mali Nitin B, Thatte Urmila M, Gogtay Nithya |
| A Prediction Algorithm for Drug Response in Patients with Mesial Temporal Lobe Epilepsy Based on Clinical and Genetic Information. PloS one 2017 12 (1): e0169214. Silva-Alves Mariana S, Secolin Rodrigo, Carvalho Benilton S, Yasuda Clarissa L, Bilevicius Elizabeth, Alvim Marina K M, Santos Renato O, Maurer-Morelli Claudia V, Cendes Fernando, Lopes-Cendes Isc |
| Effect of CYP2C19, UGT1A8, and UGT2B7 on valproic acid clearance in children with epilepsy: a population pharmacokinetic model. European journal of clinical pharmacology 2018 Aug 74 (8): 1029-1036. Mei Shenghui, Feng Weixing, Zhu Leting, Li Xingang, Yu Yazhen, Yang Weili, Gao Baoqin, Wu Xiaojuan, Fang Fang, Zhao Zhiga |
| CYP2C9 polymorphisms in epilepsy: influence on phenytoin treatment. Pharmacogenomics and personalized medicine 2018 4 11 51-58. Silvado Carlos Eduardo, Terra Vera Cristina, Twardowschy Carlos Alexand |
| Impact of CYP2C19 and CYP2C9 gene polymorphisms on sodium valproate plasma concentration in patients with epilepsy. European journal of hospital pharmacy : science and practice 2020 Aug . Song Cangsang, Li Xingde, Mao Panpan, Song Wenbing, Liu Lu, Zhang Ya |
| CYP2C9 (*2&*3) and CYP2C19 (*2&*3) polymorphisms among children with nonlesional epilepsy: a single-center study. Acta neurologica Belgica 2020 Jul . Eltalal Samah, El Ayouty Mostafa, El-Said Afaf, Wahba Yah |
| An association between the rs1799853 and rs1057910 polymorphisms of CYP2C9, the rs4244285 polymorphism of CYP2C19 and the prevalence rates of drug-resistant epilepsy in children. The International journal of neuroscience 2020 6 131 (12): 1147-1154. Makowska Marianna, Smolarz Beata, Bry? Magdalena, Forma Ewa, Romanowicz Han |
| CYP2C19 & UGT1A6 genetic polymorphisms and the impact on Valproic acid-induced weight gain in people with epilepsy: Prospective genetic association study. Epilepsy research 2021 10 177 106786. Mani Balachandran, Nair Pradeep Pankajakshan, Sekhar Anamika, Kamalanathan Sadishkumar, Narayan Sunil K, Kesavan Ramasa |
| Effects of CYP2C19 genetic polymorphisms on the pharmacokinetics of lacosamide in Korean patients with epilepsy. Epilepsia 2022 Aug . Ahn Seon-Jae, Oh Jaeseong, Kim Do-Yong, Son Hyoshin, Hwang Sungeun, Shin Hye-Rim, Kim Eun Young, Lee Han Sang, Lee Woo-Jin, Moon Jangsup, Lee Soon-Tae, Jung Keun-Hwa, Park Kyung-Il, Jung Ki-Young, Lee SeungHwan, Yu Kyung-Sang, Chu Kon, Lee Sang K |
| VARIANTS OF THE FORMATION AND COURSE OF DRUG-RESISTANT EPILEPSY IN CHILDREN WITH GENETIC POLYMORPHISMS OF CYP2C9, CYP2C19, CYP3A4. Wiadomosci lekarskie (Warsaw, Poland : 1960) 2023 6 76 (5 pt 1): 1007-1013. Liudmyla M Tantsura, Olena Yu Pylypets, Dmytro V Tretiakov, Yevhen O Tantsu |
| Study of genetic variants and their clinical significance in Mexican pediatric patients with epilepsy. Gene 2023 6 877 147565. Iris A Feria-Romero, Aracely Reyes-Cuayahuitl, Justina Sosa-Maldonado, Alexia V Montes-Aparicio, Darío Rayo-Mares, Daniel Pérez-Pérez, Israel Grijalva-Otero, Sandra Orozco-Suar |
| A real-life pilot study of the clinical application of pharmacogenomics testing on saliva in epilepsy. Epilepsia open 2023 2 . Riva Antonella, Roberti Roberta, D'Onofrio Gianluca, Stella Vari Maria, Amadori Elisabetta, De Giorgis Valentina, Cerminara Caterina, Specchio Nicola, Pietrafusa Nicola, Tombini Mario, Assenza Giovanni, Cappanera Silvia, Marini Carla, Rasmini Paolo, Veggiotti Pierangelo, Zara Federico, Russo Emilio, Striano Pasqua |
| Polymorphisms Affecting the Response to Novel Antiepileptic Drugs. International journal of molecular sciences 2023 2 24 (3): . Urzì Brancati Valentina, Pinto Vraca Tiziana, Minutoli Letteria, Pallio Giovan |
| Association of variants in the ABCB1, CYP2C19 and CYP2C9 genes for Juvenile Myoclonic Epilepsy. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2023 10 . Aurelio Jara-Prado, Jorge Luis Guerrero-Camacho, Quetzalli Denisse Ángeles-López, Adriana Ochoa-Morales, David José Dávila-Ortiz de Montellano, Miguel Ángel Ramírez-García, Michelle Breda-Yepes, Reyna M Durón, Antonio V Delgado-Escueta, Diego A Barrios-González, Iris E Martínez-Juár |
| CYP2C19 genotype and sodium channel blockers in lacosamide-treated children with epilepsy: two major determinants of trough lacosamide concentration or clinical response. Therapeutic advances in neurological disorders 2024 9 17 17562864241273087. Yue Li, Hong-Li Guo, Jie Wang, Yuan-Yuan Zhang, Wei-Jun Wang, Jian Huang, Lin Fan, Ya-Hui Hu, Xiao-Peng Lu, Feng Ch |
| Overview of preclinical and clinical studies investigating pharmacokinetics and drug-drug interactions of padsevonil. Expert opinion on drug metabolism & toxicology 2024 6 . Hugues Chanteux, Merran MacPherson, Hester Kramer, Christian Otoul, Takuya Okagaki, Chiara Rospo, Steven De Bruyn, Mark Watling, Massimo Bani, David Sciberr |
| Effects of CYP2C19 and CYP2C9 polymorphisms on the efficacy and plasma concentration of lacosamide in pediatric patients with epilepsy in China. European journal of pediatrics 2024 12 184 (1): 73. Ting Zhao, Hong-Jian Li, Hui-Lan Zhang, Jing Yu, Jie Feng, Long Cui, Ke-Fang Sun, Yan Sun, Lu-Hai |
- Page last reviewed:Feb 1, 2024
- Content source: